Medicure (OTCMKTS:MCUJF – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01, Zacks reports. Medicure had a negative return on equity of 42.01% and a negative net margin of 21.65%.The company had revenue of $5.79 million for the quarter, compared to analyst estimates of $3.63 million.
Medicure Price Performance
Shares of MCUJF opened at $0.80 on Friday. Medicure has a twelve month low of $0.68 and a twelve month high of $0.97. The stock’s 50 day moving average is $0.83 and its two-hundred day moving average is $0.84. The firm has a market capitalization of $8.39 million, a PE ratio of -1.71 and a beta of 0.97. The company has a current ratio of 1.02, a quick ratio of 0.77 and a debt-to-equity ratio of 0.03.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Featured Articles
- Five stocks we like better than Medicure
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
- MarketBeat Week in Review – 05/18 – 05/22
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
